Maris Tech director reports option holdings

Maris Tech Ltd. director Marshak Isabela filed an initial statement of beneficial ownership, reporting two option grants over ordinary shares.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Maris Tech Ltd. director Marshak Isabela filed an initial statement of beneficial ownership, reporting two option grants over ordinary shares. She holds options to buy 2,500 shares at $1.0000 per share expiring on December 27, 2027, and options to buy 5,000 shares at $1.0600 per share expiring on March 3, 2029. Footnotes explain that each grant vests 50% after 24 months, with the remaining 50% vesting in eight equal quarterly installments.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Marshak Isabela

Role Director

Type	Security	Shares	Price	Value
holding	Share option (right to buy)	--	--	--
holding	Share option (right to buy)	--	--	--

Holdings After Transaction: Share option (right to buy) — 7,500 contracts (Direct)

Footnotes (2)

F1. The options granted on December 28, 2022. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following December 28, 2022; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.
F2. The options granted on March 4, 2024. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following the vesting commencement date of January 15, 2024; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Maris Tech (MTEK) director Marshak Isabela report in this Form 3?

Marshak Isabela reports existing option holdings, not new trades. She discloses two option grants over ordinary shares, confirming her derivative position and vesting terms as a company director, without reporting any share purchases or sales.

How many Maris Tech (MTEK) shares underlie Marshak Isabela’s reported options?

The options cover 7,500 underlying ordinary shares in total. One grant relates to 2,500 shares and the other to 5,000 shares, giving a clear view of her potential future equity if the options are exercised.

What are the exercise prices of Marshak Isabela’s Maris Tech (MTEK) options?

The options have exercise prices of $1.0000 and $1.0600 per share. These prices set the cost at which she may buy Maris Tech ordinary shares if she exercises the options before their expiration dates.

When do Marshak Isabela’s Maris Tech (MTEK) options expire?

The reported options expire in 2027 and 2029, respectively. One grant ends on December 27, 2027, and the other on March 3, 2029, defining the time window during which she may exercise these rights.

How do Marshak Isabela’s Maris Tech (MTEK) options vest over time?

Each option grant vests 50% after 24 months, then quarterly. The remaining 50% vests in eight equal quarterly installments of 6.25% each, aligning her compensation with multi‑year service at Maris Tech.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 04:42 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Marshak Isabela

(Last)

(First)

(Middle)

C/O MARIS-TECH LTD.

2 YITZHAK MODAI STREET ISRAEL

(Street)

REHOVOT

7608804

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Maris Tech Ltd. [ MTEK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share option (right to buy)	⁽¹⁾	12/27/2027	Ordinary shares	2,500	$1	D
Share option (right to buy)	⁽²⁾	03/03/2029	Ordinary shares	5,000	$1.06	D

Explanation of Responses:

1. The options granted on December 28, 2022. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following December 28, 2022; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.

2. The options granted on March 4, 2024. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following the vesting commencement date of January 15, 2024; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.

	/s/ Isabela Marshak	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR